Multiple biological predictors for vulnerable carotid lesions

Cerebrovascular Diseases

Volumn 28, Issue 6, 2009, Pages 601-610

  Pelisek, Jaroslav ^a   Rudelius, Martina ^a   Zepper, Peter ^a   Poppert, Holger ^a   Reeps, Christian ^a   Schuster, Tibor ^a   Eckstein, Hans Henning ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Biomarker; Carotid artery; Inflammatory factors; Matrix metalloproteinases; Vulnerable plaques

Indexed keywords

BIOLOGICAL MARKER; GELATINASE A; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MATRILYSIN; NEUTROPHIL COLLAGENASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RELIABILITY;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID STENOSIS; FEMALE; HUMANS; INTERLEUKINS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE; STROKE; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70350070324     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000247605     Document Type: Article

References (30)

1. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C: Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521-1526.
2. Rothwell PM, Gutnikov SA, Warlow CP: Reanalysis of the final results of the European Carotid Surgery Trial. Stroke 2003; 34: 514-523.
3. Virmani R, Burke AP, Farb A, Kolodgie FD: Pathology of the vulnerable plaque. J Am Coll Cardiol 2006; 47:C13-C18.
4. Chalela JA: Evaluating the carotid plaques: going beyond stenosis. Cerebrovasc Dis 2009; 27(suppl 1):19-24.
5. Wahlgren CM, Zheng W, Shaalan W, Tang J, Bassiouny HS: Human carotid plaque calcification and vulnerability: relationship between degree of plaque calcification, fibrous cap inflammatory gene expression and symptomatology. Cerebrovasc Dis 2009; 27: 193-200.
6. Moreno PR, Purushothaman KR, Sirol M, Levy AP, Fuster V: Neovascularization in human atherosclerosis. Circulation 2006; 113: 2245-2252. (Pubitemid 43755148)
7. Newby AC: Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 2005; 85: 1-31.
8. Sundström J, Vasan RS: Circulating biomarkers of extracellular matrix remodeling and risk of atherosclerotic events. Curr Opin Lipidol 2006; 17: 45-53.
9. Ferri N, Paoletti R, Corsini A: Biomarkers for atherosclerosis: pathophysiological role and pharmacological modulation. Curr Opin Lipidol 2006; 17: 495-501.
10. Lind L: Circulating markers of inflammation and atherosclerosis. Atherosclerosis 2003; 169: 203-214.
11. Wu JT, Wu LL: Linking inflammation and atherogenesis: soluble markers identified for the detection of risk factors and for early risk assessment. Clin Chim Acta 2006; 366: 74-80.
12. Takahashi W, Ohnuki T, Ohnuki Y, Kawada S, Takagi S: The role of high-sensitivity Creactive protein in asymptomatic intra- and extracranial large artery diseases. Cerebrovasc Dis 2008; 26: 549-555.
13. Borrelli V, di Marzo L, Sapienza P, Colasanti M, Moroni E, Cavallaro A: Role of plateletderived growth factor and transforming growth factor beta1 in the regulation of metalloproteinase expressions. Surgery 2006; 140: 454-463.
14. Turu MM, Krupinski J, Catena E, Rosell A, Montaner J, Alvarez-Sabin J, Cairols M, Badimon L: Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound. Atherosclerosis 2006; 187: 161-169.
15. Alvarez B, Ruiz C, Chacon P, Alvarez-Sabin J, Matas M: Serum values of MMP-2 and MMP-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis. J Vasc Surg 2004; 40: 469-475.
16. Sapienza P, di Marzo L, Borrelli V, Sterpetti AV, Mingoli A, Piagnerelli R, Cavallaro A: Basic fibroblast growth factor mediates carotid plaque instability through metalloproteinase-2 and -9 expression. Eur J Vasc Endovasc Surg 2004; 28: 89-97.
17. Molloy KJ, Thompson MM, Schwalbe EC, Bell PR, Naylor AR, Loftus IM: Elevation in plasma MMP-9 following carotid endarterectomy is associated with particulate cerebral embolisation. Eur J Vasc Endovasc Surg 2004; 27: 409-413.
18. Bicknell CD, Peck D, Lau NM, Alkhamesi NA, Cowling MG, Clark MW, Jenkins MP, Wolfe JH, Darzi AW, Cheshire NJ: The relationship between plasma MMP-1, -7, -8 and -13 levels and embolic potential during carotid endoluminal intervention. Eur J Vasc Endovasc Surg 2004; 28: 500-507.
19. Thakore AH, Guo CY, Larson MG, Corey D, Wang TJ, Vasan RS, D'Agostino RB Sr, Lipinska I, Keaney JF Jr, Benjamin EJ, O'Donnell CJ: Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol 2007; 99: 1598-1602.
20. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Benjamin EJ, D'Agostino RB, Vasan RS: Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2000; 355: 2631-2639.
21. Addabbo F, Mallamaci F, Leonardis D, Tripepi R, Tripepi G, Goligorsky MS, Zoccali C: Searching for biomarker patterns characterizing carotid atherosclerotic burden in patients with reduced renal function. Nephrol Dial Transplant 2007; 22: 3521-3526.
22. Stary HC: Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler Thromb Vasc Biol 2000; 20: 1177-1178.
23. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM: Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20: 1262-1275.
24. Benjamini Y, Hochberg T: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995; 85: 289-300.
25. Dollery CM, Libby P: Atherosclerosis and proteinase activation. Cardiovasc Res 2006; 69: 625-635.
26. Lemaitre V, D'Armiento J: Matrix metalloproteinases in development and disease. Birth Defects Res C Embryo Today 2006; 78: 1-10.
27. Wu YW, Yang WS, Chen MF, Lee BC, Hung CS, Liu YC, Jeng JS, Huang PJ, Kao HL: High serum level of matrix metalloproteinase-1 and its rapid surge after intervention in patients with significant carotid atherosclerosis. J Formos Med Assoc 2008; 107: 93-98.
28. Wight TN, Merrilees MJ: Proteoglycans in atherosclerosis and restenosis: key roles for versican. Circ Res 2004; 94: 1158-1167.
29. Libby P, Sukhova G, Lee RT, Galis ZS: Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol 1995; 25(suppl 2):S9-S12.
30. Ito T, Ikeda U: Inflammatory cytokines and cardiovascular disease. Curr Drug Targets Inflamm Allergy 2003; 2: 257-265.